What our Customers are saying
I’ve been closely engaged with ScitoVation on projects for the last 3 years, helping a consortium of 14 global companies address a generic problem that impacts all of them. These companies either don’t have the expertise or can’t dedicate a resource to address the challenge. ScitoVation’s creative approach using PBPK modeling is notable because not only are they innovative, but they are also accountable with budgets and timelines, practical and easy to work with.
Meeting the Needs of Clients
Our team of pioneers is known for taking the time to understand the problem of each client and create an approach that best addresses their challenge. In many cases, we create custom approaches to help the client move quickly to their next research stage. This could be a go or no go decision, mode of action, or submission to a regulatory body. Our clients not only benefit from our expertise, but also time and cost savings.
July 11, 2022
Andy Nong Joins ScitoVation as Director of Computational Toxicology
DURHAM, N.C. (PRWEB)July 11, 2022 ScitoVation announced today the new Director of Computational Toxicology, Andy Nong PhD, formerly Health Canada’s Acting Manager of the Exposure and Biomonitoring Division and Principal Research Scientist for the Computational Toxicology Laboratory of the Environmental Health Sciences and Research Bureau. Dr Nong has been developing toxicokinetic and biological modeling research to advance alternative risk assessment
June 2, 2022
Increasing Scientific Confidence in Reliable and Relevant Approaches for Regulatory Testing – A Respiratory Toxicity Case Study
Please join Dr. Amy Clippinger and Dr. Andreas Stucki as they share their experience with New Approach Methods and regulatory testing; walking us through their case study on Respiratory Toxicity. What you’ll learn: To gain confidence in new approach methodologies (NAMs) for predicting human health effects, it is essential to focus on the relevance of the test system to human
July 19, 2022
Implementing Mode-of-Action Investigative Toxicology into Risk Assessments Through New Alternative Approaches
Posted by Leslie Recio, PhD DABT Like all the biological sciences, the genomic revolution has significantly impacted the science and practice of toxicology. Although regulatory toxicology relies on animal studies for use in risk assessments, there is an ongoing shift to non-animal test methods and use of genomic tools in the safety assessment of new drug candidates and environmental chemicals